Key result
Pressure gradient-guided iliac stenting resolves claudication and normalizes ABI at 3 months.
Why the study?
Intravascular ultrasound is the gold standard for evaluating equivocal lesions in symptomatic aortoiliac occlusive disease, but stringent insurance reimbursement policies and resource constraints frequently limit its availability, necessitating invasive translesional pressure gradients as a physiological alternative to digital subtraction angiography.
Does invasive translesional pressure gradient-guided endovascular revascularization resolve claudication and normalize ankle-brachial index in a patient with symptomatic bilateral aortoiliac occlusive disease and an equivocal common iliac artery lesion?
Case Report (n=1)
No
Does invasive translesional pressure gradient-guided endovascular revascularization resolve claudication and normalize ankle-brachial index in a patient with symptomatic bilateral aortoiliac occlusive disease and an equivocal common iliac artery lesion?
In resource-constrained settings where intravascular ultrasound is not reimbursed, invasive translesional pressure gradient measurement provides an objective, cost-effective physiological assessment to guide stenting of borderline iliac artery stenoses.
Answers are grounded in this paper and cite their sources.
May aid decision-making for equivocal aortoiliac lesions when IVUS unavailable; leaves open prospective validation against intravascular ultrasound.
Background: Intravascular ultrasound (IVUS) is widely considered the gold standard for determining the clinical significance of equivocal lesions in symptomatic aortoiliac occlusive disease (AIOD). However, stringent health insurance reimbursement policies and resource constraints frequently limit its availability. In such scenarios, invasive translesional pressure gradients serve as a crucial, cost-effective physiological alternative to overcome the morphological inaccuracies of digital subtraction angiography (DSA). Case Presentation: A 58-year-old male presented with severe, bilateral, life-limiting claudication. Lower extremity venous Doppler ultrasound revealed no evidence of deep vein thrombosis. Both computed tomography (CT) and peripheral angiography demonstrated bilateral common iliac artery (CIA) stenosis. Despite the use of high-resolution DSA, the morphological severity of the left CIA lesion remained ambiguous. Because national health insurance policies preclude IVUS reimbursement for this specific indication, we utilized a 4F diagnostic catheter to measure the invasive translesional pressure gradient. A peak systolic gradient of >20 mmHg was recorded, definitively confirming the lesion's hemodynamic severity. The right CIA was treated with a 6x80 mm plain balloon, whereas the critical left CIA was pre-dilated with a 7x80 mm balloon and subsequently treated with an 8x57 mm covered (graft) stent to mitigate the risk of calcific rupture and elastic recoil. During outpatient follow-ups at 1 and 3 months, the patient’s claudication had completely resolved, accompanied by a normalized resting ankle-brachial index (ABI). Conclusion: In healthcare systems where advanced intravascular imaging is restricted by reimbursement policies, the functional assessment of borderline iliac stenoses via translesional pressure gradients remains an indispensable clinical tool. It confidently prevents both clinical undertreatment and the unnecessary deployment of intravascular implants.
No takes yet. Share an insight, caveat, or question.
Spec. Dr. Halil İbrahim Tanrıseven (2026) conducted a case report in Symptomatic aortoiliac occlusive disease (bilateral common iliac artery stenosis) (n=1). Translesional pressure gradient-guided asymmetric endovascular revascularization (covered stent in left CIA, plain balloon angioplasty in right CIA) was evaluated on Resolution of claudication symptoms (Rutherford Category 0) and normalization of resting ankle-brachial index (ABI >0.90) at 1 and 3 months. Translesional pressure gradient assessment (>20 mmHg) confirmed critical left iliac stenosis and guided stenting, resolving claudication and normalizing ABI to >0.90 at 3 months.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: